Business & Tech
Waltham Company Prepares To Go Public: Report
The biotechnology company, which is working to develop anti-obesity drugs, already employs 145 people in Waltham.
WALTHAM, MA — A biotechnology business headquartered in Waltham may soon become the newest publicly traded company in Massachusetts.
Kailera Therapeutics has filed plans with the Securities and Exchange Commission for an initial public offering, the Boston Business Journal reported.
The startup is looking to develop drugs for the treatment of obesity, and since October 2024 has raised $900 million in private funds. Going public might be the next step.
Find out what's happening in Walthamfor free with the latest updates from Patch.
Kailera works out of 40,000 square feet of space at 180 Third Ave., in a complex of commercial buildings off Interstate 95/Route 128. At the start of 2026, the company had 145 full-time employees, the BBJ said.
There’s no word yet on how many shares might be offered for sale in the IPO or what the price might be. The stock would trade on the Nasdaq market under the symbol “KLRA.”
Find out what's happening in Walthamfor free with the latest updates from Patch.
To read the Business Journal story, click here.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
